 James Bardill
Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meningomyelocele | 4 | 2024 | 61 | 2.670 |
Why?
| | Spinal Dysraphism | 1 | 2024 | 107 | 0.750 |
Why?
| | Fetal Blood | 1 | 2024 | 341 | 0.740 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2024 | 208 | 0.720 |
Why?
| | Diabetic Foot | 1 | 2021 | 24 | 0.710 |
Why?
| | MicroRNAs | 2 | 2024 | 692 | 0.690 |
Why?
| | Biocompatible Materials | 3 | 2021 | 428 | 0.660 |
Why?
| | Tissue Adhesives | 1 | 2020 | 23 | 0.640 |
Why?
| | Immunohistochemistry | 1 | 2024 | 1739 | 0.630 |
Why?
| | Urea | 1 | 2020 | 81 | 0.630 |
Why?
| | Fetoscopy | 1 | 2018 | 30 | 0.580 |
Why?
| | Dopamine | 1 | 2020 | 309 | 0.520 |
Why?
| | Diabetes Mellitus | 2 | 2022 | 1077 | 0.480 |
Why?
| | Gels | 3 | 2021 | 83 | 0.470 |
Why?
| | Biomarkers | 1 | 2024 | 4190 | 0.400 |
Why?
| | Pregnancy | 6 | 2024 | 7092 | 0.390 |
Why?
| | Wound Healing | 3 | 2025 | 350 | 0.370 |
Why?
| | Amniotic Fluid | 2 | 2024 | 79 | 0.340 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2018 | 181 | 0.250 |
Why?
| | Pregnancy Trimester, Third | 1 | 2024 | 117 | 0.210 |
Why?
| | Polymers | 2 | 2018 | 495 | 0.200 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2025 | 199 | 0.200 |
Why?
| | Prenatal Diagnosis | 1 | 2024 | 190 | 0.200 |
Why?
| | Caloric Restriction | 1 | 2024 | 126 | 0.190 |
Why?
| | Infant, Newborn | 2 | 2024 | 6289 | 0.190 |
Why?
| | Reactive Oxygen Species | 1 | 2025 | 634 | 0.190 |
Why?
| | Administration, Topical | 1 | 2021 | 150 | 0.180 |
Why?
| | Materials Testing | 2 | 2019 | 354 | 0.160 |
Why?
| | Bivalvia | 1 | 2020 | 7 | 0.160 |
Why?
| | Animals | 9 | 2025 | 37748 | 0.160 |
Why?
| | Fetus | 2 | 2021 | 802 | 0.150 |
Why?
| | Female | 8 | 2025 | 75943 | 0.150 |
Why?
| | Spinal Cord | 1 | 2021 | 376 | 0.150 |
Why?
| | Mice | 6 | 2025 | 18108 | 0.150 |
Why?
| | Sheep | 1 | 2021 | 874 | 0.150 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2018 | 25 | 0.140 |
Why?
| | Acrylic Resins | 1 | 2018 | 47 | 0.140 |
Why?
| | Fibroblasts | 2 | 2025 | 1020 | 0.140 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 85 | 0.140 |
Why?
| | Gold | 1 | 2019 | 119 | 0.140 |
Why?
| | Acrylamides | 1 | 2018 | 67 | 0.140 |
Why?
| | Sulfones | 1 | 2018 | 127 | 0.140 |
Why?
| | Delayed-Action Preparations | 1 | 2018 | 177 | 0.140 |
Why?
| | Animals, Newborn | 1 | 2020 | 870 | 0.130 |
Why?
| | Spina Bifida Cystica | 1 | 2017 | 2 | 0.130 |
Why?
| | Disease Models, Animal | 3 | 2025 | 4421 | 0.130 |
Why?
| | Tissue Scaffolds | 1 | 2019 | 213 | 0.130 |
Why?
| | Case-Control Studies | 1 | 2024 | 3597 | 0.130 |
Why?
| | Inflammation | 2 | 2025 | 2902 | 0.120 |
Why?
| | Nanoparticles | 1 | 2022 | 484 | 0.120 |
Why?
| | Hydrogels | 2 | 2022 | 687 | 0.120 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2018 | 554 | 0.120 |
Why?
| | Retinal Ganglion Cells | 1 | 2016 | 117 | 0.120 |
Why?
| | Tissue Engineering | 1 | 2019 | 429 | 0.110 |
Why?
| | Myocytes, Cardiac | 1 | 2019 | 536 | 0.110 |
Why?
| | Myocardium | 1 | 2019 | 928 | 0.100 |
Why?
| | DNA-Binding Proteins | 1 | 2020 | 1485 | 0.100 |
Why?
| | Prospective Studies | 1 | 2024 | 7777 | 0.090 |
Why?
| | Transcription Factors | 1 | 2020 | 1712 | 0.090 |
Why?
| | Lung | 1 | 2024 | 4136 | 0.090 |
Why?
| | Brain | 1 | 2021 | 2868 | 0.080 |
Why?
| | Humans | 5 | 2024 | 141749 | 0.070 |
Why?
| | Superoxides | 1 | 2025 | 217 | 0.050 |
Why?
| | Cerium | 1 | 2022 | 17 | 0.050 |
Why?
| | Male | 2 | 2020 | 70179 | 0.050 |
Why?
| | Adult | 1 | 2024 | 39391 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2025 | 5909 | 0.040 |
Why?
| | Rats | 2 | 2019 | 5637 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2019 | 245 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2025 | 1334 | 0.040 |
Why?
| | Injections, Subcutaneous | 1 | 2018 | 166 | 0.040 |
Why?
| | Fetal Growth Retardation | 1 | 2024 | 582 | 0.030 |
Why?
| | Macrophages | 1 | 2025 | 1562 | 0.030 |
Why?
| | Placenta | 1 | 2024 | 769 | 0.030 |
Why?
| | Neovascularization, Physiologic | 1 | 2018 | 182 | 0.030 |
Why?
| | Biomedical Engineering | 1 | 2017 | 27 | 0.030 |
Why?
| | Biomimetics | 1 | 2016 | 43 | 0.030 |
Why?
| | Nerve Regeneration | 1 | 2016 | 59 | 0.030 |
Why?
| | Neurites | 1 | 2016 | 51 | 0.030 |
Why?
| | Neural Tube Defects | 1 | 2017 | 64 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2024 | 2828 | 0.030 |
Why?
| | Axons | 1 | 2016 | 198 | 0.030 |
Why?
| | Retina | 1 | 2016 | 314 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2525 | 0.030 |
Why?
| | Cell Movement | 1 | 2017 | 990 | 0.020 |
Why?
| | Myocardial Infarction | 1 | 2019 | 1069 | 0.020 |
Why?
|
|
Bardill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|